Skip to main content

Show 20 results Show all

Subcutaneous DMPA key facts: Answering questions and dispelling common myths about a new type of injectable contraception

This brief offers concise, evidence-based information to help answer common questions and dispel myths about injectable contraception. Myths are not stated directly because repeating a myth may reinforce it in people’s minds.

Institutional Author(s): PATH
Publication date: October, 2019

PowerPoint template: Expanding options and access with subcutaneous DMPA, a new type of injectable contraception

This customizable slide deck provides a brief description of DMPA-SC and its benefits; an overview of evidence on how the product expands access through multiple delivery channels; and illustrative policy and advocacy gaps and recommendations for country decision-makers.

Institutional Author(s): PATH
Publication date: October, 2019

Policy brief template: Scaling-Up Self-Injection of DMPA-SC to Increase Contraceptive Access and Options

A customizable document that provides a brief description of DMPA-SC; an overview of evidence on how the product expands access through multiple delivery channels; and policy and advocacy recommendations for country decision-makers tied to the country’s stage of access.

Institutional Author(s): PATH
Publication date: October, 2019

Important policies for advancing access to subcutaneous DMPA

Offers an overview of key policies that affect introduction and scale-up of injectable contraceptives, including DMPA-SC.

Institutional Author(s): PATH
Publication date: 2019

Advocacy Strategy Development Template: Planning to Achieve DMPA-SC Policy Change

A 10-part framework that supports individuals and organizations to develop a high-impact, outcome-oriented policy advocacy strategy.

Institutional Author(s): PATH
Publication date: August, 2019

Increasing access to subcutaneous DMPA in Uganda: An advocacy case study

Describes key evidence-building efforts, advocacy actions, and policy changes in Uganda brought about by key partners to increase access to injectable contraception, including DMPA-SC. You can draw on lessons learned from Uganda to inform your policy goals and advocacy strategy for increasing method choice and access with DMPA-SC in your country.

Institutional Author(s): PATH
Publication date: August, 2019

DMPA and HIV: What advocates need to know

Summarizes important takeaways for advocates from the latest guidance released by the World Health Organization on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV.

Institutional Author(s): PATH
Publication date: August, 2019

The Future of DMPA-SC: Expanding access and options in 2019

The working meeting on “The Future of DMPA-SC: Expanding access and options in 2019” was held in November 2018 as a pre-meeting before the International Conference on Family Planning (ICFP) in Kigali, Rwanda was intended to bring together colleagues and partners working to introduce and scale-up subcutaneous DMPA (DMPA-SC or SC) in 14 countries to exchange challenges, successes, and lessons learned—and to plan together how they can continue to expand women’s access and options with DMPA-SC.

Institutional Author(s): PATH
Publication date: January, 2019

Report The Future of DMPA-SC: Expanding access and options in 2019

Key actions for advocates to advance subcutaneous DMPA

Provides examples of actions that may be useful in advancing access to DMPA-SC, including those that apply to different country stages.

Institutional Author(s): PATH
Publication date: August, 2017

Common terms for DMPA injectable contraception

This brief helps you understand the terms surrounding DMPA injectables to inform your messaging and communication.

Institutional Author(s): PATH
Publication date: 2017